Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. - Wikidata - awgldk - TriplyDB

Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.

Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.

http://www.wikidata.org/entity/Q35980098

about

Hepatitis E Pathogenesis Hepatitis E virus: An ancient hidden enemy in Latin America Epidemiology of Hepatitis E Virus in European Countries Chronic hepatitis E: A brief review Chronic hepatitis e virus infection and treatment Therapeutic targets for the treatment of hepatitis E virus infection Hepatitis E Virus in Industrialized Countries: The Silent Threat Hepatitis E infection in HIV-infected liver and kidney transplant candidates.An analysis of the benefit of using HEV genotype 3 antigens in detecting anti-HEV IgG in a European population Hepatitis E virus chronic infection of swine co-infected with Porcine Reproductive and Respiratory Syndrome Virus.Hepatitis E virus infection in HIV-infected persons Epidemiology of HEV in the Mediterranean basin: 10-year prevalence in Italy Increased Hepatitis E Virus Seroprevalence Correlates with Lower CD4+ Cell Counts in HIV-Infected Persons in Argentina Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, France Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran Serological evidence for a hepatitis e virus-related agent in goats in the United States Acute and Chronic Hepatitis E Virus Infection in Human Immunodeficiency Virus-Infected U.S. Women.Hepatitis B and E co-primary infections in an HIV-1-infected patient.Human immunodeficiency virus and liver disease forum 2012.Hepatitis E virus infection.Host immune status and response to hepatitis E virus infection.Seroepidemiology of hepatitis E virus infection in an urban population in Zambia: strong association with HIV and environmental enteropathy.Risk factors for hepatitis E virus infection and disease.Is hepatitis E virus an emerging problem in industrialized countries?Hepatitis E: latest developments in knowledge.Liver involvement in human immunodeficiency virus infection.Clinical Manifestations of Hepatitis E.Identification of a Novel Hepatitis E Virus Genotype 3 Strain Isolated from a Chronic Hepatitis E Virus Infection in a Kidney Transplant Recipient in Switzerland.Seroprevalence of hepatitis E in HIV infected patients in Greece.Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.Seroprevalence of hepatitis E virus in domestic pigs and wild boars in Switzerland.Patients infected with HIV are at high-risk for hepatitis E virus infection in Spain.Chronic hepatitis E in HIV patients: rapid progression to cirrhosis and response to oral ribavirin.Hepatitis E virus infection in patients infected with human immunodeficiency virus in an endemic area in Iran.Hepatitis e virus infection in sheltered homeless persons, france.Hepatitis E virus seroprevalence and correlates of anti-HEV IgG antibodies in the Rakai District, Uganda.Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic.Seroprevalence of anti-hepatitis E virus and anti-Salmonella antibodies in pigs at slaughter in Switzerland.The emergence of hepatitis E virus in Europe

P2860

Q26741395-70643E6D-0A04-4BC2-B653-96ACD2FC096C Q26768538-E150AA3B-7C7F-45F7-8A7B-FA35648B3A52 Q26777824-D351F544-7365-4FD4-9F94-3246BF8F0BDC Q26784271-9D58D473-8FE5-4E90-94D3-03ECA8E4908A Q26996422-717B73B4-7C10-4E23-AA9B-DDCDDE30C707 Q28084036-0146461F-DE34-4A1B-9CFA-82C8CF95FC58 Q28354374-FCB65AC3-5B2E-4CBA-B009-358C0916968D Q33849330-39EDB22A-39D1-4744-AA83-146AC4F29087 Q34717939-9ACA026C-C21E-4BAE-A43F-7AD193C70663 Q35686552-955C431C-F678-4456-8B6E-B7B35822E687 Q35844426-4F45DABB-6C89-4C0A-B748-2EC56B972E93 Q35884983-FE6A1AF9-3DFD-4422-BD3E-5B5F924DDAA6 Q36088591-FC240754-4577-48E5-B23F-FEE5E276D15C Q36148094-4C8187AD-1D67-464C-A6AE-4CB57F481C98 Q36327306-9F95CD76-64C3-4BC6-8C4C-4FA6E7242AF8 Q36420009-6ABC6D57-972F-453C-8786-6703C0D0459F Q36609717-8C1899DC-1C9D-47E4-A80E-4CE7554F8D23 Q36667638-759FF7D5-ABD8-4F7E-B6AA-F4143D764D2C Q37361082-195CA2BE-88EE-4518-917D-8E84AC1705FE Q37544935-D4AD363D-EF98-4A1B-9A63-380D15369539 Q37544940-18A10975-28D2-4C76-9649-2A839B1EF1F0 Q37582311-EB1D0BAF-B30F-4B95-A87F-8B4FB3DC7494 Q38268414-8DFD0FCE-D8DB-42A7-A804-3079330EE0D3 Q38547282-428CF190-7CA0-4D22-8EF1-F561B67751BD Q38839954-3B483276-8C5C-4D06-9F48-EF565B862A43 Q38852184-9CD9E4C1-6ED4-49CF-862E-9ADE07EEF68D Q40085149-68545C6D-4C31-431B-A5DC-4682E2C9CE3D Q40195807-A328876E-4225-4ECC-A199-53DF02A619FB Q40949031-99DE267A-ECCB-4F2D-A720-5E5CEBB50BC5 Q41927277-381F09ED-35CA-4BAA-944D-BF81471C8D71 Q42238945-F9304535-B6BB-498F-B355-6172BE40AF10 Q42261558-1CA9C969-B2B8-4488-8245-C0B7F1AEB836 Q42267237-C9409478-5A23-4BA1-A451-C97652DF2A14 Q42274833-D072B1EB-6FDD-436A-9777-F5EAD6867F46 Q43180430-2CDEEAE6-EDE2-450D-9119-6B6067386717 Q45324099-756F0D44-A4B8-49C5-94B0-80641BF8735E Q45355509-85C6815C-DB31-420F-94F4-F27AC89995FE Q45355759-6F28AFAA-3995-45B4-9EB0-08AC1C950340 Q57241777-67A9E29F-4FE0-4FC1-ABC3-A6E560683043

P2860

Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland.

http://www.wikidata.org/entity/Q35980098

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Hepatitis E Virus seroprevalen ...... atients with HIV, Switzerland.

@ast

Hepatitis E Virus seroprevalen ...... atients with HIV, Switzerland.

@en

type

label

Hepatitis E Virus seroprevalen ...... atients with HIV, Switzerland.

@ast

Hepatitis E Virus seroprevalen ...... atients with HIV, Switzerland.

@en

prefLabel

Hepatitis E Virus seroprevalen ...... atients with HIV, Switzerland.

@ast

Hepatitis E Virus seroprevalen ...... atients with HIV, Switzerland.

@en

P1433

Q35980098-6B144A7A-2AF3-43C2-8B1A-ED7A583472A8

P1476

Q35980098-C8294653-57D9-44FE-B393-CA75206B33E1

P2093

Q35980098-09AB0A1B-7990-4249-809D-DD36073ADCF9

Q35980098-0A311D4E-BADB-4901-B049-24BB9B193431

Q35980098-244865ED-ED59-46CA-8269-D2DD844D1CBF

Q35980098-3C9CF846-9A59-4055-B63E-C05CFD7C56FD

Q35980098-3F41FF37-5464-4DCD-822C-2BC4ACE6AF29

Q35980098-4769E727-64E8-459E-A612-20BF1A413488

Q35980098-B1B1316A-6833-42AB-813B-9CB9C57429EB

Q35980098-CED65868-8333-4625-BCF5-9CA8CE12B78C

Q35980098-CFA28599-2F1C-4786-AFE9-9F6DF46556B8

Q35980098-D5952D70-99B4-4E9E-88AB-7D257EA34156

P2860

Q35980098-02CAA87A-2222-47AF-B926-F12F0B7B7B3B

Q35980098-36D6B653-F741-4CF5-8A8C-0418FA549851

Q35980098-4F786CD7-E1E3-466E-853B-88635B5BDBC8

Q35980098-5AE1634A-3307-4D5B-B5AF-AAB4924D2D92

Q35980098-71999E3F-8546-48F2-BD5C-72F828A2CB0A

Q35980098-72F790DD-CD04-46AD-B979-B6D82CAC85FB

Q35980098-99EE84A1-C8BB-4353-BF55-625323AD6FC4

Q35980098-9D65CF61-638C-4B37-8822-E2343100F7C2

Q35980098-A19C4B2F-BF15-48E6-B2EE-82A7900145C2

Q35980098-C24A1350-F30A-4518-B7A2-A142AD39F8C2

P304

Q35980098-511A5CE5-C093-4FF5-919F-B78779A3AA41

P31

Q35980098-8B3A5916-1902-4BB0-B5C3-0204D87F7D2A

P356

Q35980098-39311D2C-82AB-46C2-A2EB-D1771AB845C9

Q35980098-FD456DE4-1FFF-41C2-843F-878366A8CBFB

P433

Q35980098-766E1831-C604-48EC-8536-0BCEFBD1D67A

P478

Q35980098-76D82209-4C14-4F28-BA65-4D7E9F1A001B

P50

Q35980098-20741101-844A-4072-9F1E-2B462C5D3984

Q35980098-47EDC932-7983-4019-87BD-99A0C20D515F

Q35980098-BC301B72-B5F7-4131-8296-B3CF2C53180B

Q35980098-F66F8EE0-153B-40C6-918E-E9A4C2CED94D

P577

Q35980098-5E639F53-2175-4A74-B93F-6F68BC639CD3

P5875

Q35980098-482E8956-6219-4AAD-9680-0F1946DC2A4B

P698

Q35980098-F507311F-21AF-4AB7-B6A6-DB7724A53E35

P921

Q35980098-824676E1-C2FF-41B1-B6F4-0FE65A054AF3

P932

Q35980098-669F554F-BB30-4247-A33A-25A3B06AF68B

P356

P1433

Emerging Infectious Diseases

P1476

Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland

@en

P2093

Andrea Witteck

http://www.w3.org/2001/XMLSchema#string

Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland

http://www.w3.org/2001/XMLSchema#string

Franziska Schöni-Affolter

http://www.w3.org/2001/XMLSchema#string

Helen Kovari

http://www.w3.org/2001/XMLSchema#string

Jacques Izpopet

http://www.w3.org/2001/XMLSchema#string

John-Marc Evison

http://www.w3.org/2001/XMLSchema#string

Josef Jost

http://www.w3.org/2001/XMLSchema#string

Katharine E A Darling

http://www.w3.org/2001/XMLSchema#string

Laurent Kaiser

http://www.w3.org/2001/XMLSchema#string

Luigia Elzi

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.

Chronic hepatitis E virus infection in liver transplant recipients.

Hepatitis E virus genotype 3 diversity, France.

Hepatitis E in high-income countries.

Acute hepatitis E virus infection in an HIV-infected person in the United States.

Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.

Hepatitis E virus in HIV-infected patients.

Persistent carriage of hepatitis E virus in patients with HIV infection.

Hepatitis E virus as a newly identified cause of acute viral hepatitis during human immunodeficiency virus infection.

Hepatitis E virus and chronic hepatitis in organ-transplant recipients.

P304

1074-1078

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3201/EID/1706.101067

http://www.w3.org/2001/XMLSchema#string

10.3201/EID1706.101067

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Darius Moradpour

Matthias Cavassini

Florence Abravanel

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51486271

http://www.w3.org/2001/XMLSchema#string

P698

21749774

http://www.w3.org/2001/XMLSchema#string

P921

P932

3358194

http://www.w3.org/2001/XMLSchema#string